Heart Disease Trial, Recruiting NCT05548413 Sponsor: Jia-Rong Wu Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05548413
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients with heart failure:

  • People who have a confirmed diagnosis of heart failure (either the pumping or relaxing type)
  • People who have had trouble taking their heart failure medications as prescribed
  • People who have a care partner (such as a spouse, child, partner, relative, or friend) who is the main person helping with their heart failure care
  • People who are willing to have their care partner involved in helping with their medications
  • People who have been on a stable dose of heart failure medications for at least 3 months, following a full heart failure assessment
  • People who live in a situation where they are responsible for taking their own medications
  • People who are willing to use an electronic pill box called SimpleMed+ to track medication taking
  • People who can be reached by phone

For care partners:

  • Unpaid family members, friends, partners, or other people who help with the patient's care at least 3 times a week, and who have been chosen by the patient
  • People who are willing to take part in the program together with the patient
  • People who are 18 years of age or older

Who may not be able to join:

For patients with heart failure:

  • People with cognitive impairment that makes it difficult to understand and agree to participate
  • People who have been hospitalised in the 3 months before joining the study
  • People who have end-stage kidney disease, a terminal illness such as advanced cancer, or any other condition where life expectancy is less than one year
  • People with a psychotic illness
  • People with current alcohol dependence or other substance misuse
  • People who are unable to communicate in English or have another significant communication barrier
  • People who are currently taking part in, or have recently taken part in, a similar self-care program within the past year

For care partners:

  • People with cognitive impairment that makes it difficult to understand and agree to participate
  • People who have a terminal illness
  • People who are unable to communicate in English or have another significant communication barrier

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jia-Rong Wu, University of Kentucky

Phone: 8593234712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jia-Rong Wu
Registry
ClinicalTrials.gov
Start date
4 January 2023
Est. completion
30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Medication adherence; Self-reported medication adherence.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov